ケトコナゾールとサイクロスポリン

CYP2D6-inhibiting drugs and risk of fall injury after newly initiated therapy with beta-blockers-a register-based case-crossover study.

Scientific reports·2025

Trends in intentional and unintentional poisonings among older adults - A national register-based study in Sweden.

BMC geriatrics·2023

Environmental assessment of landfill gas mitigation using biocover and gas collection with energy utilisation at aging landfills.

Waste management (New York, N.Y.)·2023

Performance of a cryo-cooled crystal monochromator illuminated by hard X-rays with MHz repetition rate at the European X-ray Free-Electron Laser.

Optics express·2022

Pump-probe X-ray holographic imaging of laser-induced cavitation bubbles with femtosecond FEL pulses.

Nature communications·2021

Materials Imaging and Dynamics (MID) instrument at the European X-ray Free-Electron Laser Facility.

Journal of synchrotron radiation·2021

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Revealing Griffithsin recognition of diverse virus-associated <i>N</i>-glycans using atomistic simulations: glycan compositions and branching patterns as key molecular determinants.

Physical chemistry chemical physics : PCCP·2026

Metabolite glues as a means of purine sensing and chemotherapeutic response.

Nature·2026

Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTAC.

Nature communications·2026

Multifunctional polysaccharides for skin health: A review in antioxidant, anti-inflammatory, and regenerative mechanisms.

International journal of biological macromolecules·2026

Recent advances in the formulation and delivery applications of chitosan/Fucoidan nanoparticles.

International journal of biological macromolecules·2026

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

Vaccine·2026

関連する実験動画

ケトコナゾールとサイクロスポリン

関連する概念動画

CYP2D6-inhibiting drugs and risk of fall injury after newly initiated therapy with beta-blockers-a register-based case-crossover study.

Trends in intentional and unintentional poisonings among older adults - A national register-based study in Sweden.

Environmental assessment of landfill gas mitigation using biocover and gas collection with energy utilisation at aging landfills.

Performance of a cryo-cooled crystal monochromator illuminated by hard X-rays with MHz repetition rate at the European X-ray Free-Electron Laser.

Pump-probe X-ray holographic imaging of laser-induced cavitation bubbles with femtosecond FEL pulses.

Materials Imaging and Dynamics (MID) instrument at the European X-ray Free-Electron Laser Facility.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Revealing Griffithsin recognition of diverse virus-associated <i>N</i>-glycans using atomistic simulations: glycan compositions and branching patterns as key molecular determinants.

Metabolite glues as a means of purine sensing and chemotherapeutic response.

Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTAC.

Multifunctional polysaccharides for skin health: A review in antioxidant, anti-inflammatory, and regenerative mechanisms.

Recent advances in the formulation and delivery applications of chitosan/Fucoidan nanoparticles.

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

関連する実験動画

ケトコナゾールとサイクロスポリン

関連する概念動画

関連記事